IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $591,319 | +100.4% | 72,733 | +12.1% | 0.11% | +81.0% |
| Q3 2023 | $295,127 | -25.6% | 64,863 | +15.1% | 0.06% | -20.3% |
| Q2 2023 | $396,641 | +26.9% | 56,341 | +10.1% | 0.08% | -12.2% |
| Q1 2023 | $312,643 | +33.6% | 51,169 | +39.7% | 0.09% | -60.4% |
| Q4 2022 | $234,008 | -34.6% | 36,621 | -2.1% | 0.23% | -31.0% |
| Q3 2022 | $358,000 | -17.7% | 37,401 | -5.2% | 0.33% | -0.6% |
| Q2 2022 | $435,000 | -38.0% | 39,434 | -6.5% | 0.33% | 0.0% |
| Q1 2022 | $702,000 | -28.7% | 42,183 | -18.2% | 0.33% | -7.5% |
| Q4 2021 | $984,000 | – | 51,540 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |